10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
BRISTOL MYERS SQUIBB CO | ||
Ticker: BMY Fiscal Year: 2011 | ||
CONSOLIDATED BALANCE SHEETS | ||
Period Ending Dec 31, 2011 10-K (Filed: Feb 17, 2012) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2011 | Dec 31, 2010 | |
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | $ 5,776 | 5,033 |
| Marketable securities | 2,957 | 2,268 |
| Receivables | 3,743 | 3,480 |
| Inventories | 1,384 | 1,204 |
| Deferred income taxes | 1,200 | 1,036 |
| Prepaid expenses and other | 258 | 252 |
| Total Current Assets | 15,318 | 13,273 |
| Property, plant and equipment | 4,521 | 4,664 |
| Goodwill | 5,586 | 5,233 |
| Other intangible assets | 3,124 | 3,370 |
| Deferred income taxes | 688 | 850 |
| Marketable securities | 2,909 | 2,681 |
| Other assets | 824 | 1,005 |
| Total Assets | 32,970 | 31,076 |
| LIABILITIES | ||
| Current Liabilities: | ||
| Short-term borrowings | 115 | 117 |
| Accounts payable | 2,603 | 1,983 |
| Accrued expenses | 2,791 | 2,740 |
| Deferred income | 337 | 402 |
| Accrued rebates and returns | 1,170 | 857 |
| U.S. and foreign income taxes payable | 167 | 65 |
| Dividends payable | 597 | 575 |
| Total Current Liabilities | 7,780 | 6,739 |
| Pension, postretirement, and postemployment liabilities | 2,017 | 1,297 |
| Deferred income | 866 | 895 |
| U.S. and foreign income taxes payable | 573 | 755 |
| Other liabilities | 491 | 424 |
| Long-term debt | 5,376 | 5,328 |
| Total Liabilities | 17,103 | 15,438 |
| Commitments and contingencies (Note 22) | 0 | 0 |
| EQUITY | ||
| Bristol-Myers Squibb Company Shareholders' Equity: | ||
| Preferred stock, $2 convertible series, par value $1 per share: Authorized 10 million shares; issued and outstanding 5,268 in 2011 and 5,269 in 2010, liquidation value of $50 per share | 0 | 0 |
| Common stock, par value of $0.10 per share: Authorized 4.5 billion shares; 2.2 billion issued in both 2011 and 2010 | 220 | 220 |
| Capital in excess of par value of stock | 3,114 | 3,682 |
| Accumulated other comprehensive loss | (3,045) | (2,371) |
| Retained earnings | 33,069 | 31,636 |
| Less cost of treasury stock - 515 million common shares in 2011 and 501 million in 2010 | (17,402) | (17,454) |
| Total Bristol-Myers Squibb Company Shareholders' Equity | 15,956 | 15,713 |
| Noncontrolling interest | (89) | (75) |
| Total Equity | 15,867 | 15,638 |
| Total Liabilities and Equity | 32,970 | 31,076 |
| External Links | |
| BRISTOL MYERS SQUIBB CO (BMY) Fiscal Year 2011 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |